1. Home
  2. DK vs SYRE Comparison

DK vs SYRE Comparison

Compare DK & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DK
  • SYRE
  • Stock Information
  • Founded
  • DK 2001
  • SYRE 2013
  • Country
  • DK United States
  • SYRE United States
  • Employees
  • DK N/A
  • SYRE N/A
  • Industry
  • DK Integrated oil Companies
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • DK Energy
  • SYRE Health Care
  • Exchange
  • DK Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • DK 1.0B
  • SYRE 841.4M
  • IPO Year
  • DK 2006
  • SYRE 2016
  • Fundamental
  • Price
  • DK $21.78
  • SYRE $15.92
  • Analyst Decision
  • DK Hold
  • SYRE Buy
  • Analyst Count
  • DK 12
  • SYRE 6
  • Target Price
  • DK $17.48
  • SYRE $55.00
  • AVG Volume (30 Days)
  • DK 1.6M
  • SYRE 616.7K
  • Earning Date
  • DK 08-05-2025
  • SYRE 08-06-2025
  • Dividend Yield
  • DK 4.76%
  • SYRE N/A
  • EPS Growth
  • DK N/A
  • SYRE N/A
  • EPS
  • DK N/A
  • SYRE N/A
  • Revenue
  • DK $11,366,100,000.00
  • SYRE N/A
  • Revenue This Year
  • DK N/A
  • SYRE N/A
  • Revenue Next Year
  • DK N/A
  • SYRE N/A
  • P/E Ratio
  • DK N/A
  • SYRE N/A
  • Revenue Growth
  • DK N/A
  • SYRE N/A
  • 52 Week Low
  • DK $11.03
  • SYRE $10.91
  • 52 Week High
  • DK $25.68
  • SYRE $40.26
  • Technical
  • Relative Strength Index (RSI)
  • DK 59.15
  • SYRE 42.76
  • Support Level
  • DK $20.49
  • SYRE $14.09
  • Resistance Level
  • DK $21.66
  • SYRE $17.29
  • Average True Range (ATR)
  • DK 0.93
  • SYRE 1.23
  • MACD
  • DK -0.16
  • SYRE -0.22
  • Stochastic Oscillator
  • DK 42.40
  • SYRE 16.89

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. Delek's logistics segment sells portions of the petroleum products its refineries produce. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: